Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
19
NCT02864082
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 8, 2017
Completion: Dec 4, 2018